These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36587212)

  • 1. Clinical features of cancer with unknown primary site (clinical features, treatment, prognosis of cancer with unknown primary site).
    Yang H; He F; Xu W; Cao Z
    BMC Cancer; 2022 Dec; 22(1):1372. PubMed ID: 36587212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological, molecular and prognostic characteristics of cancer of unknown primary in China: An analysis of 1420 cases.
    Qi P; Sun Y; Liu X; Wu S; Wo Y; Xu Q; Wang Q; Hu X; Zhou X
    Cancer Med; 2023 Jan; 12(2):1177-1188. PubMed ID: 35822433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and management of metastatic neoplasms with unknown primary.
    Bochtler T; Löffler H; Krämer A
    Semin Diagn Pathol; 2018 May; 35(3):199-206. PubMed ID: 29203116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors among patients with brain metastases from cancer of unknown primary site.
    Simões Padilla C; Ho VKY; van der Strate IH; Leenders WPJ; de Vos FYFL; Veldhuijzen van Zanten SEM; Loef C
    J Neurooncol; 2022 Sep; 159(3):647-655. PubMed ID: 35976548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of presumed breast or ovarian cancer among patients with unfavorable-subset cancer of unknown primary site.
    Kodaira M; Yonemori K; Shimoi T; Yoshida A; Yoshida M; Kitano A; Shimomura A; Yunokawa M; Shimizu C; Takiguchi Y; Fujiwara Y; Tamura K
    BMC Cancer; 2018 Feb; 18(1):176. PubMed ID: 29433539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and therapeutic management of cancer of an unknown primary.
    Pavlidis N; Briasoulis E; Hainsworth J; Greco FA
    Eur J Cancer; 2003 Sep; 39(14):1990-2005. PubMed ID: 12957453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic approach to cancer of unknown primary site].
    Fernández Cotarelo MJ; Guerra Vales JM
    Rev Clin Esp; 2009; 209(7):347-51. PubMed ID: 19709540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unfavorable carcinoma of unknown primary with a gastrointestinal profile: a retrospective study.
    Guidi L; Valenza C; Battaiotto E; Trapani D; Ghioni MC; Crimini E; Boscolo Bielo L; Venetis K; Belli C; Bottiglieri L; Gervaso L; Cella CA; Ciardiello D; Spada F; Benini L; Adorisio R; Mane E; Fazio N; Guerini Rocco E; Curigliano G; Zampino MG
    ESMO Open; 2024 Aug; 9(8):103662. PubMed ID: 39111110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine tumors of unknown primary site: gold dust or misdiagnosed neoplasms?
    Catena L; Bichisao E; Milione M; Valente M; Platania M; Pusceddu S; Ducceschi M; Zilembo N; Formisano B; Bajetta E
    Tumori; 2011; 97(5):564-7. PubMed ID: 22158484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of prognostic factors in 68 patients with cancer of unknown primary site].
    Kou XG; Liang DL; Zhang QQ; Li XR; Zhao YZ; Gu JF; Lu P
    Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):783-6. PubMed ID: 22335913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Standards, Options and Recommendations for the management of patient with carcinoma of unknown primary site].
    Bugat R; Bataillard A; Lesimple T; Voigt JJ; Culine S; Lortholary A; Merrouche Y; Ganem G; Kaminsky MC; Negrier S; Perol M; Laforêt C; Bedossa P; Bertrand G; Coindre JM; Fizazi K;
    Bull Cancer; 2002 Oct; 89(10):869-75. PubMed ID: 12441278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and predictors for tumor site origin in metastatic adenocarcinoma of unknown primary site.
    Li X; Shao Y; Sheng L; Zhu J; Wang Z; Guo K; Sun L
    Cancer Med; 2021 Feb; 10(3):974-988. PubMed ID: 33405390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and outcomes of cervical lymph node metastasis from unknown primary sites: a single institution's 14-year experience.
    Zhou M; Wu Y; Wu Y; Li H; Ye B; Yue K; Jing C; Duan Y; Wang X
    Eur J Med Res; 2023 Jan; 28(1):5. PubMed ID: 36597158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Squamous cell carcinoma of cervical lymph nodes from an unknown primary site: a retrospective analysis of treatment strategies and prognosis].
    Lou JL; Guo L; Zhao JQ; Wang SY
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Jan; 48(1):32-6. PubMed ID: 23656813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to Diagnose and Treat a Cancer of Unknown Primary Site.
    Tomuleasa C; Zaharie F; Muresan MS; Pop L; Fekete Z; Dima D; Frinc I; Trifa A; Berce C; Jurj A; Berindan-Neagoe I; Zdrenghea M
    J Gastrointestin Liver Dis; 2017 Mar; 26(1):69-79. PubMed ID: 28338116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of patients with cancer of unknown primary site.
    Hainsworth JD; Greco FA
    Oncology (Williston Park); 2000 Apr; 14(4):563-74; discussion 574-6, 578-9. PubMed ID: 10826316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical recommendations for diagnosis, treatment and monitoring of patients with cancer of unknown primary site].
    Bišof V; Juretić A; Trivanović D; Dintinjana RD; Sarçević B; Jakić-Razumović J; Ban M; Bošković L; Mise B-; Bura M; Stančić-Rokotov D
    Lijec Vjesn; 2015; 137(3-4):65-9. PubMed ID: 26065281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cancer of unknown primary site origin--advances in diagnosis and therapy].
    Plot L; Dovrish Z; Hadari R; Weisenberg N; Zehavi T; Nisenbaum B; Amital H
    Harefuah; 2008 Apr; 147(4):294-8, 376, 375. PubMed ID: 18686808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone metastasis and poor performance status are prognostic factors for survival of carcinoma of unknown primary site in patients treated with systematic chemotherapy.
    Kodaira M; Takahashi S; Yamada S; Ueda K; Mishima Y; Takeuchi K; Yamamoto N; Ishikawa Y; Yokoyama M; Saotome T; Terui Y; Hatake K
    Ann Oncol; 2010 Jun; 21(6):1163-1167. PubMed ID: 20019088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma of unknown primary site: presentation, treatment, and prognosis--a single institution study. University of Pennsylvania Pigmented Lesion Study Group.
    Anbari KK; Schuchter LM; Bucky LP; Mick R; Synnestvedt M; Guerry D; Hamilton R; Halpern AC
    Cancer; 1997 May; 79(9):1816-21. PubMed ID: 9129001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.